Georg-Nikolaus Franke Konstantin Dumann Madlen Jentzsch Astrid Monecke Christine Doehring Claudia Nehring-Vucinic Sebastian Schwind Dietger Niederwieser Uwe Platzbecker Mirjana Ziemer Vladan Vucinic
10.3389/fonc.2021.749691
Front Oncol
2021 Dec 9;11:749691.
sezary syndrome allogeneic hematopietic stem cell transplantation brentuximab vedodin graft vs leukemia effect non-myeloablative conditioning
CC BY
https://pubmed.ncbi.nlm.nih.gov/34956873/
Case Reports
PMC8695846
34956873
Case Report: Graft Versus Tumor Effect After Non-Myeloablative Allogeneic Stem-Cell Transplantation in a Patient With Brentuximab-Vedotin Refractory Sezary Syndrome
2021